These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2782249)

  • 21. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
    Schmidt A; König W; Binner L; Mayer U; Stauch M
    Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia.
    Morady F; Scheinman MM; Shen E; Shapiro W; Sung RJ; DiCarlo L
    Am J Cardiol; 1983 Jan; 51(1):156-9. PubMed ID: 6401373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
    Mooss AN; Mohiuddin SM; Hee TT; Esterbrooks DJ; Hilleman DE; Rovang KS; Sketch MH
    Am J Cardiol; 1990 Mar; 65(9):609-14. PubMed ID: 2178383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
    Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
    Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K
    Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia.
    Klein RC; Machell C; Rushforth N; Standefur J
    Am Heart J; 1988 Jan; 115(1 Pt 1):96-101. PubMed ID: 3336990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
    Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
    Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous amiodarone for treating acute life threatening arrhythmias.
    Votey SR; Herbert ME
    West J Med; 1998 Mar; 168(3):183. PubMed ID: 9549418
    [No Abstract]   [Full Text] [Related]  

  • 29. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control of tachycardia with intravenous amiodarone in acute left heart failure].
    Tomcsányi J; Arabadzisz H; Zsoldos A; Marosi A; Beck K
    Orv Hetil; 2001 Dec; 142(52):2899-901. PubMed ID: 11828940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
    Waleffe A; Mary-Rabine L; Legrand V; Demoulin JC; Kulbertus HE
    Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous amiodarone for ventricular arrhythmias: overview and clinical use.
    Gonzalez ER; Kannewurf BS; Ornato JP
    Resuscitation; 1998; 39(1-2):33-42. PubMed ID: 9918445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy and safety of intravenous Amiodarone in infants and children.
    Figa FH; Gow RM; Hamilton RM; Freedom RM
    Am J Cardiol; 1994 Sep; 74(6):573-7. PubMed ID: 8074040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
    Hohnloser SH; Meinertz T; Dammbacher T; Steiert K; Jähnchen E; Zehender M; Fraedrich G; Just H
    Am Heart J; 1991 Jan; 121(1 Pt 1):89-95. PubMed ID: 1985383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.